Govt Job: For Ph.D, M.Pharm, M.Sc at NIAB | Salary Rs. 60,670 pm

NIAB is an autonomous and premier institute of the Department of Biotechnology, Government of India.

The Institute aims to develop and harness novel and emerging biotechnological tools and applications, and take up research in cutting-edge areas for improving animal health and productivity as well as contribute to human health and welfare.

Post : One position of Research Associate-II or Principal Project Associate

Applications are invited from suitable candidates for filling up the following positions at National Institute of Animal Biotechnology (NIAB), Hyderabad against the DBT funded project entitled “Establishment of a Consortium for One Health to address Zoonotic and Transboundary Diseases in India, including the Northeast Region”. Coordinator : Dr. Subeer Majumdar, PI: Dr. Nagendra R. Hegde.

Eligibility for Research Associate-II : PhD in any field of Life Sciences (incl. Veterinary Science, Biotechnology, Biochemistry, Microbiology, etc.) or MD/MS/MDS and at least one years’ research experience, OR MVSc / M.Pharm / ME / MTech and at least 4 years’ research experience

Eligibility for Principal Project Associate : (i) Master’s degree in Natural or Agricultural Sciences or Bachelor’s degree in Engineering and Technology or Medicine from a recognised University or equivalent, and 8 years’ experience in Research and Development in industrial or academic institutions or science and technology organisations and scientific activities and services, OR

(ii) Doctoral degree in Science / Engineering / Technology / Pharma or MD / MS from a recognised University of equivalent, and 4 years’ experience in Research and Development in industrial or academic institutions or science and technology organisations and scientific activities and services

Desirable experience : PCR, RT-PCR, Protein expression and purification, Serological assay development and/or validation, Serosurvey.

Age limit : 40 years (Relaxation is admissible in case of SC/ST/OBC candidates as per Government instructions)

Fellowship amount : Rs. 49,000/-PM +24% HRA (if applicable) as per the DST guidelines

Applications are to be filled ONLINE. Online link for submission of application is available from 25-04-2022 and the last date is 14-05-2022 at 05:00 pm.

Candidates must fill online application form at niab.org.in.

Candidates are advised to fill the online application form in sufficient time before the last date to avoid last minute technical issues.

Suitable candidates will be screened, intimated through email and interviewed online by duly constituted selection committee.

Original documents in support of date of birth, educational qualifications, experience certificates are required to be submitted at the time of joining.

No need to send hard copy. Interim enquiries will not be entertained.

Related Posts

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

Basel- Roche announced today that the cobas® MPX-E assay, a qualitative in-vitro test for the detection and discrimination of Human Immunodeficiency Virus (HIV 1 and 2) and Hepatitis C, B,…

Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

Chandigarh: In a major push to strengthen public healthcare, the Haryana Government has directed all government hospitals to maintain medicine stock records on a real-time centralised portal, ensuring transparency and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial